IGC is positioned to be at the forefront of one of the fastest growing industries in America.
IGC is taking defensible, high growth, high margin positions in two of the world's fastest growing industries. Our involvement in the electronics and pharmaceutical cannabis industries creates unique synergies and advantages. Our positions will be highly profitable in the short and long term.
We foresee that the legalization of the cannabis industry will create an explosion in demand for cannabinoid-based pharmaceutical therapies, technology, facilities, and financial services. While early, we expect to have a first mover advantage by developing novel therapies, applying for patents, and acquiring technologies from related industries to crossover to cannabis once federal laws permit. Currently, our involvement in the cannabis industry is based on developing phytocannabinoid-based therapies as intellectual property (IP). Our strategy is to refrain from testing, cultivating, or financing growers in the United States. We have assembled a team of distinguished scientists to pursue our strategy.
- We have filed five provisional patent applications and continue to develop phytocannabinoid-based therapies for the treatment of a wide range of life altering or life threatening conditions.
- We continue to acquire talent with expertise in building state-of-the-art facilities that can be used to grow pharmaceutical grade cannabis when laws permit.
- We provide research on the legal cannabis industry and investment banking services for peripheral businesses, while heeding to interstate commerce laws and regulations.
Our legacy business includes equipment rental for the agricultural and infrastructure industries.
Our expertise in electronics gives us a cost advantage in cannabis facility construction.
Our international presence gives us a cost advantage in pharmaceutical development.